Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

An H5 type avian influenza antigen has been identified at a broiler farm in Ganghwa-gun, Incheon. The Agriculture, Food and ...

Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Some households that ordered the COVID-19 antigen tests have expressed concern about receiving kits nearing their expiration ...

A family physician encouraged the use of shared decision-making, following the discussion with patients of the pros and cons ...

Discover a novel approach to reduce relapse rates for blood cancers treated via the revolutionary CAR T-cell therapy.

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, ...